Kidney transplantation in Alport's syndrome.

Francesco Scolari,B. Valzorio,F. Fasciolo,O. Carli,V. Vizzardi,P. Gaggia,P. Tira,R. Maffeis,Stefano Bonardelli,Rosario Maiorca

DOI: https://doi.org/10.1159/000059892

1997-10-22

Contributions to Nephrology

Abstract:

What problem does this paper attempt to address?

Metabolism and thermoregulation in the forest shrew Myosorex varius (Soricidae: Crocidurinae).

C. Brown,E. Hunter,R. Baxter

DOI: https://doi.org/10.1016/S0300-9629(97)00223-5

1997-12-01

Abstract:
Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and Mirnas

Sisi Zhou,Tao Hu,Gaohua Han,Yafeng Wu,Xin Hua,Juan Su,Weiwei Jin,Yiping Mou,Xiaozhou Mou,Quan Li,Songqin Liu

DOI: https://doi.org/10.1002/smll.202004492

IF: 13.3

2020-01-01

Small

Abstract:Exosomes are recognized as promising biomarkers for early cancer diagnosis and prognosis owing to a large amount of biological information they carried. But the key is that single type of exosomal biomarker analysis is not sufficient enough for accurate cancer diagnosis and stage monitoring due to the insufficient information and high false positive signal. To address the challenge, here simultaneous in situ detection of different types of exosomal biomarkers (surface proteins: CD81, ephrin type-A receptor 2, and carbohydrate antigen 19-9; miRNAs: miR-451a, miR-21, and miR-10b) is conducted with a 3D microfluidic chip, which works in conjunction with quantum dot (QD) labeling and vesicle fusion technology. After exosomes are efficiently captured by the microfluidic chip, the quantification of multiple exosomal proteins is achieved by using three kinds of QDs with the same excitation and different emission wavelengths, and virus-mimicking fusogenic vesicles encapsulating three exquisitely engineered molecular beacons are introduced for ultrasensitive detection of multiple exosomal miRNAs without requiring RNA extraction. Through comprehensive profiling different types of exosomal biomarkers, the false positive rate is substantially avoided and the accuracy of cancer diagnosis and stage monitoring is improved to approximate to 100%, which are critical to cancer effective treatment and favorable prognosis.
Comparison of fenestrations in internal elastic laminae of canine thoracic and abdominal aortas.

S. H. Song,M. R. Roach

DOI: https://doi.org/10.1159/000158499

Blood & Vessel

Abstract:All non-elastin tissue was removed from canine aortas by placing them in 0.1 N NaOH at 75 degrees C for varying periods of time. The segments of aorta were weighed in a Mettler Chemical Balance at intervals. In 10 dogs the average weight of the thoracic aorta was 5.01 +/- 0.388 (SE) g while that of the abdominal aorta was 3.08 +/- 0.346 g. After digestion, the thoracic aorta weighed 3.34 +/- 0.0275 g and the abdominal aorta 0.85 +/- 0.085 g. Thus, the elastin makes up 67% of the thoracic aorta but only 28% of the abdominal aorta. These are equivalent to 0.334 g/kg body weight for the thoracic aorta and 0.224 g/kg body weight for the abdominal aorta. The values were always stable between 5 and 7 h and usually between 3 and 12 h. Aortic elastin was obtained from 5 dogs after 5-7 h of digestion and prepared for analysis by scanning electron microscopy. The dimensions of the fenestrations in the internal elastic laminae were quantified as described previously. The lower abdominal aorta had the largest holes (2.227 +/- 0.048 micron), and the upper thoracic aorta the smallest holes (0.954 +/- 0.032 micron). There was no significant difference in the size of the fenestrations along the thoracic aorta, but those in the lower abdominal aorta were larger than those in the upper abdominal aorta. The possible significance of the fenestrations in the genesis of aortic disease is discussed briefly.
Highly sensitive microfluidic sensor using integrated optical fiber and real-time single-cell Raman spectroscopy for diagnosis of pancreatic cancer

Renhao Ni,Kaixin Ge,Yang Luo,Tong Zhu,Zeming Hu,Min Li,Pan Tao,Jinyi Chi,Guanron Li,Haojun Yuan,Qian Pang,Wanlei Gao,Peiqing Zhang,Yabin Zhu

DOI: https://doi.org/10.1016/j.bios.2024.116616

2024-08-03

Abstract:Pancreatic cancer is notoriously lethal due to its late diagnosis and poor patient response to treatments, posing a significant clinical challenge. This study introduced a novel approach that combines a single-cell capturing platform, tumor-targeted silver (Ag) nanoprobes, and precisely docking tapered fiber integrated with Raman spectroscopy. This approach focuses on early detection and progression monitoring of pancreatic cancer. Utilizing tumor-targeted Ag nanoparticles and tapered multimode fibers enhances Raman signals, minimizes light loss, and reduces background noise. This advanced Raman system allows for detailed molecular spectroscopic examination of individual cells, offering more practical information and enabling earlier detection and accurate staging of pancreatic cancer compared to conventional multicellular Raman spectroscopy. Transcriptomic analysis using high-throughput gene screening and transcriptomic databases confirmed the ability and accuracy of this method to identify molecular changes in normal, early, and metastatic pancreatic cancer cells. Key findings revealed that cell adhesion, migration, and the extracellular matrix are closely related to single-cell Raman spectroscopy (SCRS) results, highlighting components such as collagen, phospholipids, and carotene. Therefore, the SCRS approach provides a comprehensive view of the molecular composition, biological function, and material changes in cells, offering a novel, accurate, reliable, rapid, and efficient method for diagnosing and monitoring pancreatic cancer.
Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Daren Liu,Liping Cao,Jiekai Yu,Risheng Que,Wenzhi Jiang,Yiming Zhou,Linhua Zhu

DOI: https://doi.org/10.1159/000178883

IF: 3.977

2009-01-01

Pancreatology

Abstract:Background: To develop a serum-specific protein fingerprint which is capable of differentiating samples from patients with pancreatic cancer and those with other pancreatic conditions. Methods: We used SELDI-TOF-MS coupled with CM10 chips and bioinformatics tools to analyze a total of 118 serum samples in this study; 78 serum samples were analyzed to establish the diagnostic models and the other 40 samples were analyzed on the second day as an independent test set. Results: The analysis of this independent test set yielded a specificity of 91.6% and a sensitivity of 91.6% for pattern 1, which distinguished pancreatic adenocarcinoma (PC) from healthy individuals and a specificity of 80.0% and a sensitivity of 90.9% for pattern 2, which distinguished PC from chronic pancreatitis. Conclusion: This study indicated that the SELDI-TOF-MS technique can facilitate the discovery of better serum tumor biomarkers and a combination of specific models is more accurate than a single model in diagnosis Of PC.
Nanomaterials Augmented LDI-TOF-MS for Pancreatic Ductal Adenocarcinoma Diagnosis and Classification.

Yaolin Xu,Dansong Wang,Tiantao Kuang,Wenchuan Wu,Xuefeng Xu,Dayong Jin,Hua Zhang,Sheng Zhong,Yunbing Wang,Wenhui Lou

DOI: https://doi.org/10.1200/jco.2020.38.15_suppl.e16761

IF: 45.3

2020-01-01

Journal of Clinical Oncology

Abstract:e16761 Background: Pancreatic ductal adenocarcinoma (PAAD) is one type of cancer with poor prognosis. Although CA 19-9 was the most common serological marker for cancer screening and surveillance after treatment, there are still unignorable limitations, including low sensitivity, possible false-negatives/positives owing to confounding conditions. Reliable non-invasive diagnostics is in urgent need. As PAAD is increasingly considered as a metabolic disorder, serum metabolite profiling is becoming critical to reveal important cancer-related bioinformation. This work proposes a novel LDI-TOF-MS technique for PAAD screening and diagnosis. Methods: An LDI-TOF-MS platform was established for cancer screening. All mass spectrum was collected within a mass range of 100 to 1,100 Da, while the spectra were manually examined using the FlexAnalysis 3.4 software (Bruker Daltonics, Bremen, Germany). In a typical process, 0.5 uL of serum samples were spotted on a polished steel target plate MTP 384 and air-dried followed by another 1 uL of GNS or SiNW nanomaterials. The spectra were then acquired in the reflection positive mode with smartbeam-II laser at 355 nm with laser frequency of 1,000 Hz. A random walk of 25 shots at raster spot and 20 different spots were measured for each individual sample, therefore, 500 satisfactory shots were obtained. Results: By taking advantage of 3D nanostructures and machine learning, we applied proposed approach to 94 patients with PAAD, as well as 203 healthy controls (Table). The results demonstrated an average sensitivity of 99% and a specificity over 98% in detecting cancers. 11 of 94 PAAD patients (11.70%) were CA 19-9 negative (CA19-9 < 37U/ml, stage I n = 2, stage II n = 7, stage III n = 1 and stage IV n = 1). LDI-TOF-MS recognized almost all CA 19-9-negative PAAD. The sensitivity and specificity were obviously superior to CA 19-9 in PAAD: only 1 of 94 PAAD (1.06%) were misclassified as healthy controls. In contrast, CA19-9 positive and CA 19-9 negative PAADs were not readily distinguished by this method. Therefore, this method was independent of tumor markers. Conclusions: Result suggested strong potential of proposed technique as a low-cost, superior precision, and high-throughput procedure for PAAD diagnosis and beyond. [Table: see text]
Biofluids Metabolic Profiling Based on PS@Fe 3 O 4 –NH 2 Magnetic Beads-Assisted LDI-MS for Liver Cancer Screening

Liuying He,Xiao Wang,Junyu Chen,Yuze Li,Liping Wang,Caiqiao Xiong,Zongxiu Nie

DOI: https://doi.org/10.1021/acs.analchem.2c00654

IF: 7.4

2022-07-15

Analytical Chemistry

Abstract:Liver cancer (LC) is the third frequent cause of death worldwide, so early diagnosis of liver cancer patients is crucial for disease management. Herein, we applied NH2-coated polystyrene@Fe3O4 magnetic beads (PS@Fe3O4-NH2 MBs) as a matrix material in laser desorption/ionization mass spectrometry (LDI-MS). Rapid, sensitive, and selective metabolic profiling of the native biofluids was achieved without any inconvenient enrichment or purification. Then, based on the selected m/z features, LC patients were discriminated from healthy controls (HCs) by machine learning, with the high area under the curve (AUC) values for urine and serum assessments (0.962 and 0.935). Moreover, initial-diagnosed and subsequent-visited LC patients were also differentiated, which indicates potential applications of this method in early diagnosis. Furthermore, among these identified compounds by FT-ICR MS, the expression level of some metabolites changed from HCs to LCs, including 29 and 12 characteristic metabolites in human urine and serum samples, respectively. These results suggest that PS@Fe3O4-NH2 MBs-assisted LDI-MS coupled with machine learning is feasible for LC clinical diagnosis.

chemistry, analytical
Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Liping Cao,Liang Wang,Guifeng Wang,Daren Liu,Jiekai Yu,Risheng Que,Dafei Xie

DOI: https://doi.org/10.3892/ijo_00000804

2010-01-01

International Journal of Oncology

Abstract:A serum-specific protein 'fingerprint' model was established which is capable of evaluating the effect of chemotherapy (gemcitabine) of pancreatic adenocarcinoma. We used SELDI-TOF-MS coupled with CM10 chips and bioinformatics tools to analyze a total of 45 mouse serum samples from three groups: the healthy control group, the pancreatic cancer model group (orthotopic transplantation model of human pancreatic adenocarcinoma) and the gemcitabine-treated group to establish diagnostic models. As a result, the test set yielded a specificity of 95.0% and a sensitivity of 95.0% for pattern 1, which distinguished pancreatic adenocarcinoma from healthy individuals and a specificity of 95.0% and a sensitivity of 75.0% for pattern 3, which distinguished healthy controls, PC model group and gemcitabine-treated group, as evaluated by leave-one-out cross-validation. We concluded from this study that the SELDI-TOF-MS technique combined with bioinformatics approaches can facilitate evaluating the effect of chemotherapy (gemcitabine) for pancreatic adenocarcinoma and could be used as a potential prognostic monitoring method.
Serum Metabolic Fingerprints on Bowl-Shaped Submicroreactor Chip for Chemotherapy Monitoring

Xia Yin,Jing Yang,Mengji Zhang,Xinyao Wang,Wei Xu,Cameron-Alexander H. Price,Lin Huang,Wanshan Liu,Haiyang Su,Wenjing Wang,Hongyu Chen,Guangjin Hou,Mark Walker,Ying Zhou,Zhen Shen,Jian Liu,Kun Qian,Wen Di

DOI: https://doi.org/10.1021/acsnano.1c09864

IF: 17.1

2022-01-31

ACS Nano

Abstract:Chemotherapy is a primary cancer treatment strategy, the monitoring of which is critical to enhancing the survival rate and quality of life of cancer patients. However, current chemotherapy monitoring mainly relies on imaging tools with inefficient sensitivity and radiation invasiveness. Herein, we develop the bowl-shaped submicroreactor chip of Au-loaded 3-aminophenol formaldehyde resin (denoted as APF-bowl&Au) with a specifically designed structure and Au loading content. The obtained APF-bowl&Au, used as the matrix of laser desorption/ionization mass spectrometry (LDI MS), possesses an enhanced localized electromagnetic field for strengthened small metabolite detection. The APF-bowl&Au enables the extraction of serum metabolic fingerprints (SMFs), and machine learning of the SMFs achieves chemotherapy monitoring of ovarian cancer with area-under-the-curve (AUC) of 0.81-0.98. Furthermore, a serum metabolic biomarker panel is preliminarily identified, exhibiting gradual changes as the chemotherapy cycles proceed. This work provides insights into the development of nanochips and contributes to a universal detection platform for chemotherapy monitoring.

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
Serum Lipidomic Fingerprints Encode Early Diagnosis and Staging of Lung Cancer on a Novel PbS/Au-Layered Substrate

Xiaopin Lai,Kaiqing Liang,Yang Su,Kunbin Guo,Xin Wang,Yanpei Wan,Cuiqiong Ye,Chengke Zhou,Rongjia Chen,Wenhua Gao,Yuping Chen,Wen Lin,Wenxiu Ni,Yan Lin,Kwan-Ming Ng

DOI: https://doi.org/10.1021/acsami.3c03693

IF: 9.5

2023-07-19

ACS Applied Materials & Interfaces

Abstract:Lung cancer (LC) is a major cause of mortality among malignant tumors. Early diagnosis through lipidomic profiling can improve prognostic outcomes. In this study, a uniform PbS/Au-layered substrate that enhances the laser desorption/ionization process, an interfacial process triggered on the substrate surface upon laser excitation, was designed to efficiently characterize the lipidomic profiles of LC patient serum. By controlling the stacking arrangement and particle sizes of PbS QDs and AuNPs,...

materials science, multidisciplinary,nanoscience & nanotechnology
Defective Fe Metal–Organic Frameworks Enhance Metabolic Profiling for High‐Accuracy Diagnosis of Human Cancers

Jing Yang,Xia Yin,Longzhou Zhang,Xiwen Zhang,Yue Lin,Linzhou Zhuang,Wanshan Liu,Ru Zhang,Xuecheng Yan,Li Shi,Wen Di,Lei Feng,Yi Jia,Jinlan Wang,Kun Qian,Xiangdong Yao

DOI: https://doi.org/10.1002/adma.202201422

IF: 29.4

2022-01-01

Advanced Materials

Abstract:Cancers heavily threaten human life; therefore, a high-accuracy diagnosis is vital to protect human beings from the suffering of cancers. While biopsies and imaging methods are widely used as current technologies for cancer diagnosis, a new detection platform by metabolic analysis is expected due to the significant advantages of fast, simple, and cost-effectiveness with high body tolerance. However, the signal of molecule biomarkers is too weak to acquire high-accuracy diagnosis. Herein, precisely engineered metal-organic frameworks for laser desorption/ionization mass spectrometry, allowing favorable charge transfer within the molecule-substrate interface and mitigated thermal dissipation by adjusting the phonon scattering with metal nodes, are developed. Consequently, a surprising signal enhancement of ≈10 000-fold is achieved, resulting in diagnosis of three major cancers (liver/lung/kidney cancer) with area-under-the-curve of 0.908-0.964 and accuracy of 83.2%-90.6%, which promises a universal detection tool for large-scale clinical diagnosis of human cancers.
Accelerated Exosomal Metabolic Profiling Enabled by Robust On‐Target Array Sintering with Metal–Organic Frameworks

Yun Wu,Yiming Qiao,Chenyu Yang,Yueying Chen,Xizhong Shen,Chunhui Deng,Qunyan Yao,Nianrong Sun

DOI: https://doi.org/10.1002/smtd.202401238

IF: 12.4

2024-09-14

Small Methods

Abstract:An on‐target sintering matrix‐based platform facilitates efficient in situ enrichment of exosomes on target and direct LDI detection. The metabolic profiles of exosomes extracted based on this platform are combined with machine learning to enable the simultaneous early diagnosis of pancreatic cancer, screening of high‐risk groups, and staging of pancreatic cancer. Pancreatic cancer is highly lethal, and survival chances improve only with early detection at a precancerous stage. However, there remains a significant gap in developing tools for large‐scale, rapid screening. To this end, a high‐throughput On‐Target Array Extraction Platform (OTAEP) by direct sintering of a series of metal–organic frameworks (MOFs) for dual in situ extraction, encompassing both exosomes and their metabolic profiles, is developed. Based on the principle of geometry‐dependent photothermal conversion efficiency and standard testing, the appropriate MOF functional unit is identified. This unit enables exosome enrichment within 10 min and metabolic fingerprint extraction in under 1 s of laser irradiation, with over five reuse. To further accelerate and enhance the quality of metabolic profile analysis, the application of Surrogate Variable Analysis to eliminate hidden confounding factors within the profiles is proposed, and five biomarkers demonstrated by MS/MS experiments are identified. These biomarkers enable early diagnosis, risk stratification, and staging of pancreatic cancer simultaneously, with sensitivity of 94.1%, specificity of 98.8%, and precision of 94.9%. This work represents a breakthrough for overcoming throughput challenges in large‐scale testing and for addressing confounding factors in big data analysis.

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
Single cell glycan-linkages profiling for hepatocellular carcinoma early diagnosis using lanthanide encoded bacteriophage MS2 based ICP-MS

Yong Liang,Zhen Liu,Dongliang Zuo,Shi Chen,Jianbin Chen,Xiaowen Yan,Pingguo Liu,Qiuquan Wang

DOI: https://doi.org/10.1016/j.talanta.2024.126056

IF: 6.1

2024-07-01

Talanta

Abstract:Early diagnosis is paramount for enhancing survival rates and prognosis in the context of malignant diseases. Hepatocellular carcinoma (HCC), the second leading cause of cancer-related deaths worldwide, poses significant challenges for its early detection. In this study, we present an innovative approach which contributed to the early diagnosis of HCC. By lanthanide encoding signal amplification to map glycan-linkages at the single-cell level, the minute quantities of "soft" glycan-linkages on single cell surface were converted into "hard" elemental tags through the use of an MS2 signal amplifier. Harnessing the power of lanthanides encoded within MS2, we achieve nearly three orders of magnitude signal amplification. These encoded tags are subsequently quantified using single-cell inductively coupled plasma mass spectrometry (SC-ICP-MS). Linear discriminant analysis (LDA) identifies seven specific glycan-linkages (α-2,3-Sia, α-Gal, α-1,2-Fuc, α-1,6-Fuc, α-2,6-Sia, α-GalNAc, and Gal-β-1,3-GalNAc) as biomarkers. Our methodology is initially validated at the cellular level with 100% accuracy in discriminating between hepatic carcinoma HepG2 cells and their normal HL7702 cells. We apply this approach to quantify and classify glycan-linkages on the surfaces of 55 clinical surgical HCC specimens. Leveraging these seven glycan-linkages as biomarkers, we achieve precise differentiation between 8 normal hepatic specimens, 40 early HCC specimens, and 7 colorectal metastasis HCC specimens. This pioneering work represents the first instance of employing single-cell glycan-linkages as biomarkers promising for the early diagnosis of HCC with a remarkable 100% predictive accuracy rate, which holds immense potential for enhancing the feasibility and precision of HCC diagnosis in clinical practice.
Diagnosis and Prognosis of Breast Cancer by High-Performance Serum Metabolic Fingerprints

Yida Huang,Shaoqian Du,Jun Liu,Weiyi Huang,Wanshan Liu,Mengji Zhang,Ning Li,Ruimin Wang,Jiao Wu,Wei Chen,Mengyi Jiang,Tianhao Zhou,Jing Cao,Jing Yang,Lin Huang,An Gu,Jingyang Niu,Yuan Cao,Wei-Xing Zong,Xin Wang,Kun Qian,Hongxia Wang

DOI: https://doi.org/10.1073/pnas.2122245119

2022-01-01

Abstract:High-performance metabolic analysis is emerging in the diagnosis and prognosis of breast cancer (BrCa). Still, advanced tools are in demand to deliver the application potentials of metabolic analysis. Here, we used fast nanoparticle-enhanced laser desorption/ionization mass spectrometry (NPELDI-MS) to record serum metabolic fingerprints (SMFs) of BrCa in seconds, achieving high reproducibility and low consumption of direct serum detection without treatment. Subsequently, machine learning of SMFs generated by NPELDI-MS functioned as an efficient readout to distinguish BrCa from non-BrCa with an area under the curve of 0.948. Furthermore, a metabolic prognosis scoring system was constructed using SMFs with effective prediction performance toward BrCa (P < 0.005). Finally, we identified a biomarker panel of seven metabolites that were differentially enriched in BrCa serum and their related pathways. Together, our findings provide an efficient serum metabolic tool to characterize BrCa and highlight certain metabolic signatures as potential diagnostic and prognostic factors of diseases including but not limited to BrCa.
Hollow multishelled heterostructures with enhanced performance for laser desorption/ionization mass spectrometry based metabolic diagnosis

Congcong Pei,Rui Su,Songting Lu,Xiaonan Chen,Yajie Ding,Rongxin Li,Weikang Shu,Yu Zeng,Yingying Lin,Liang Xu,Yuqiang Mi,Jingjing Wan

DOI: https://doi.org/10.1039/d3tb00766a

IF: 7.571

2023-01-01

Journal of Materials Chemistry B

Abstract:High-performance metabolic diagnosis-based laser desorption/ionization mass spectrometry (LDI-MS) improves the precision diagnosis of diseases and subsequent treatment.

materials science, biomaterials
ICP-MS and Photothermal Dual-Readout Assay for Ultrasensitive and Point-of-Care Detection of Pancreatic Cancer Exosomes

Yingzhi Zhang,Yunyun Wei,Peng Liu,Xuan Zhang,Zhangrun Xu,Xiaodong Tan,Mingli Chen,Jianhua Wang

DOI: https://doi.org/10.1021/acs.analchem.1c02004

IF: 7.4

2021-08-09

Analytical Chemistry

Abstract:Pancreatic cancer is known to have a high mortality rate, and its early diagnosis remains challenging due to the occult location of the pancreas. Exosomes derived from pancreatic cancer cells specifically express glypican-1, which may provide a liquid biopsy opportunity for the early diagnosis of pancreatic cancer. Herein, an inductively coupled plasma mass spectrometry (ICP-MS) and photothermal dual-readout platform was proposed for the ultrasensitive and point-of-care analysis of pancreatic cancer exosomes. In our design, exosomes were specifically captured by the sandwich immunoassay, and simultaneously, alkaline phosphatase was introduced in a low-background manner. The alkaline phosphatase triggered the hydrolysis of l-ascorbic acid 2-phosphate to produce ascorbic acid, followed by the etching of Fe3O4@MnO2 nanoflowers. As a result, the Mn2+ generated by etching stripped off the Fe3O4 and was quantified using ICP-MS. Meanwhile, the reduced Fe3O4@MnO2 was applied for the photothermal assay by oxidizing dopamine with MnO2. The protocol exhibits a detection limit down to 19.1 particles mL–1, which is the most sensitive protocol reported so far. To our knowledge, this is the first endeavor for exosome quantification using ICP-MS and photothermal methods. The developed dual-readout platform not only is capable of distinguishing pancreatic cancer patients from healthy people, but also shows excellent discernibility of individual differences at low concentrations of exosomes. This dual-readout assay is a promising platform for the ultrasensitive and point-of-care detection of exosomes in liquid biopsy-based early cancer diagnosis.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c02004.Chemicals and materials; Cell culture and exosome isolation; Schematic illustration of preparing Fe3O4@MnO2 nanoflowers; Schematic illustration of ALP-induced etching of Fe3O4@MnO2 nanoflowers; Characterization of exosomes isolated by the ultracentrifugation and magnetic separation; UV–vis absorption spectra of polydopamine nanoparticles and dopamine; Optimization of experimental parameters; Table of operating parameters for ICP-MS detection of exosomes; and Table of comparison of the developed method with the reported methods for exosome quantification (PDF)This article has not yet been cited by other publications.

chemistry, analytical
Homogeneous Multiplex Immunoassay for One-Step Pancreatic Cancer Biomarker Evaluation

Zili Huang,Ziyan Li,Min Jiang,Rui Liu,Yi Lv

DOI: https://doi.org/10.1021/acs.analchem.0c03780

2020-12-15

Abstract:Pancreatic cancer is one of the foremost malignant gastrointestinal tumors, with prognosis and postoperative prediction remaining challenging because of the lack of facile, sensitive diagnostic methods and a specific single biomarker. Combined-biomarker analysis which provides a promising strategy to conquer such dilemma still requires developments in methodologies to gain accurate and reliable outcomes with wash-/separation-free scenarios and minimal interferences. Herein, a multiplex single-particle homogeneous immunoassay was proposed by simultaneously evaluating three pancreatic cancer-related biomarkers. Owing to the excellent resolution and multielement detectors without mass spectra overlapping, single-particle ICP-MS simultaneously provided biomarkers (CA125, CEA, and CA199) with three to four order-of-magnitude linear ranges and low-level limits of detection from specific antibody-labeled noble metal nanoparticles (AuNPs, AgNPs, and PtNPs). By scrutinizing both intensity and frequency signals, the proposed method was successfully applied in patients' serological evaluation, with results correlating well with those measured by the clinical routine method. The proposed method provides a potential tool in risk assessment of disease recurrence and survival.
Label-Free Histology and Evaluation of Human Pancreatic Cancer with Coherent Nonlinear Optical Microscopy.

Lili Zhang,Xiang Zou,Jing Huang,Jie Fan,Xiangjie Sun,Bohan Zhang,Bin Zheng,Chongyuan Guo,Deliang Fu,Lie Yao,Minbiao Ji

DOI: https://doi.org/10.1021/acs.analchem.1c03861

IF: 7.4

2021-01-01

Analytical Chemistry

Abstract:Surgeries achieving maximal tumor resection remain the major effective treatment of pancreatic cancer. Rapid and precise intraoperative diagnosis of pancreatic tissues is critical for optimum surgical outcomes but is challenging for the current staining-based histological methods. We demonstrated that label-free coherent nonlinear optical microscopy with combined stimulated Raman scattering (SRS) and second harmonic generation (SHG) could reveal key diagnostic features of both normal and cancerous human pancreatic tissues. Adjacent pairs of tissue sections from resection margins of 37 patients were imaged by SRS and hematoxylin and eosin staining for direct comparison, demonstrating high diagnostic concordance (Cohen's kappa, κ > 0.97) between them. Fresh unprocessed tissues showed well-preserved histoarchitectures including pancreatic ducts, islets, acini, and nerves. Moreover, the area ratios of collagen fibers were analyzed and found to correlate with the drainage pancreatic amylase level (odds ratio = 28.0, p = 0.0017). Our results indicated that SRS/SHG histology provides potential for rapid intraoperative diagnosis of pancreatic cancer as well as a predictive value of postoperative pancreatic fistula.
Single hollow-core microstructure fiber biosensor for pancreatic cancer diagnosis in terahertz regime

Jiaqin Gong,Yani Zhang,Zhe Guang,Amanur Rahaman,Jia Xue,Qiuyang Wang,Yiming Yao,Pinna Wang,Yongkang Wang

DOI: https://doi.org/10.1088/1402-4896/ad7f00

2024-09-26

Physica Scripta

Abstract:Pancreatic cancer is a kind of malignant tumor that is difficult to detect in its early stages, developing rapidly and with a 5-year survival rate of only 5% to 10%. Therefore early diagnosis and discovery of pancreatic cancer are very important for the successful treatment of the disease. Here, we report a single hollow-core microstructural fiber (SHC-MSF) biosensor based on a ZEONEX substrate, which has been optimized for the early detection of pancreatic cancer biomarkers. The proposed SHC-MSF biosensor adopts a single-aperture structure to increase the contact range with assay analytes to improve the detection sensitivity. Its biosensing performance was numerically analyzed using a finite element method with a perfect matching layer. Numerical results demonstrated that the proposed MSF-biosensor presented ultra-high sensitivity (bilirubin: 105.55%, glucose: 105.34%, creatinine: 105.67%) and negligible confinement loss (bilirubin: 5.52×10-14 cm-1, glucose: 1.65×10-14 cm-1, creatinine: 5.57×10-14 cm-1) in the range of 0.3~2.0 THz. Moreover, the SHC-MSF biosensor could selectively detect and distinguish cancer markers of different concentrations in the blood to achieve a more accurate diagnosis of pancreatic cancer. Finally, fabrication tolerance analysis of the proposed MSF-biosensor is provided to ensure the feasibility of rapid preparation.

physics, multidisciplinary
Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.

Feng Yang,Chen Jin,Sabin Subedi,Chong Lek Lee,Qiang Wang,Yongjian Jiang,Ji Li,Yang Di,Deliang Fu

DOI: https://doi.org/10.1016/j.ctrv.2012.02.003

IF: 13.608

2012-01-01

Cancer Treatment Reviews

Abstract:Pancreatic cancer is a devastating disease with incidence increasing at an alarming rate and survival not improved substantially during the past three decades. Although enormous efforts have been made in early detection and comprehensive treatment for this disease, little or no survival improvement was obtained, which necessitates the development of novel strategies. Emerging inorganic nanomaterials, such as carbon nanotubes, quantum dots, mesoporous silica/gold/supermagnetic nanoparticles, have been widely used in biomedical research with great optimism for cancer diagnosis and therapy. Such nanoparticles possess unique optical, electrical, magnetic and/or electrochemical properties. With such properties along with their impressive nano-size, these particles can be targeted to cancer cells, tissues, and ligands efficiently and monitored with extreme precision in real-time. In additional to liposome, dendrimer, and polymeric nanoparticles, they are considered the most promising nanomaterials with the capability of both cancer detection and multimodality treatment. Emerging approaches to harness nanotechnology to optimize the existing diagnostic and therapeutic tools for pancreatic cancer have been extensively explored during the recent years. Future options for early detection, individual therapy and monitoring responses of pancreatic cancer are focused on multifunctional nanomedicine. In this review, we present the recent development of clinically applicable inorganic nanoparticles, with focus on the diagnosis and treatment of pancreatic cancer. Furthermore, their advantages in theranostic nanomedicine, and challenges of translation to clinical practice, are discussed.

Kidney transplantation in Alport's syndrome.

Metabolism and thermoregulation in the forest shrew Myosorex varius (Soricidae: Crocidurinae).

Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and Mirnas

Comparison of fenestrations in internal elastic laminae of canine thoracic and abdominal aortas.

Highly sensitive microfluidic sensor using integrated optical fiber and real-time single-cell Raman spectroscopy for diagnosis of pancreatic cancer

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Nanomaterials Augmented LDI-TOF-MS for Pancreatic Ductal Adenocarcinoma Diagnosis and Classification.

Biofluids Metabolic Profiling Based on PS@Fe 3 O 4 –NH 2 Magnetic Beads-Assisted LDI-MS for Liver Cancer Screening

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Serum Metabolic Fingerprints on Bowl-Shaped Submicroreactor Chip for Chemotherapy Monitoring

Serum Lipidomic Fingerprints Encode Early Diagnosis and Staging of Lung Cancer on a Novel PbS/Au-Layered Substrate

Defective Fe Metal–Organic Frameworks Enhance Metabolic Profiling for High‐Accuracy Diagnosis of Human Cancers

Accelerated Exosomal Metabolic Profiling Enabled by Robust On‐Target Array Sintering with Metal–Organic Frameworks

Single cell glycan-linkages profiling for hepatocellular carcinoma early diagnosis using lanthanide encoded bacteriophage MS2 based ICP-MS

Diagnosis and Prognosis of Breast Cancer by High-Performance Serum Metabolic Fingerprints

Hollow multishelled heterostructures with enhanced performance for laser desorption/ionization mass spectrometry based metabolic diagnosis

ICP-MS and Photothermal Dual-Readout Assay for Ultrasensitive and Point-of-Care Detection of Pancreatic Cancer Exosomes

Homogeneous Multiplex Immunoassay for One-Step Pancreatic Cancer Biomarker Evaluation

Label-Free Histology and Evaluation of Human Pancreatic Cancer with Coherent Nonlinear Optical Microscopy.

Single hollow-core microstructure fiber biosensor for pancreatic cancer diagnosis in terahertz regime

Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.